Evidence 1
Activity
Activity
Tumor-homing Peptides
Target
Tumor cell
Homing
Hepatocellular carcinoma
Source & Reference
TumorHoPe2.0
TumorHoPe2
Co-delivery of plantamajoside and sorafenib by a multi-functional nanoparticle to combat the drug resistance of hepatocellular carcinoma through reprograming the tumor hypoxic microenvironment
2019
Ying Zan et al. Drug Deliv. 2019 Dec
26(1):1080-1091.
Other
| Source Activity Label | Source Definition |
|---|---|
| Tumor-homing Peptides |
TumorHoPe2.0
experimentally validated tumor-homing peptide annotation.
|
Human liver cancer cell line (HepG2), Sorafenib-resistant HepG2/SOR cells
Male nude Balb/c mice (18–20g)
Synthetic
TAT(cell membrane penetrating peptide), Plantamajoside (PMS), Sorafenib (SOR), PLA-based nanoparticles